N. Palmateer

发表

Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.

A. Pharris, T. Rhodes, M. Salminen, 2014, The International journal on drug policy.

Determinants of hepatitis C antiviral effectiveness awareness among people who inject drugs in the direct-acting antiviral era.

H. Innes, S. Hutchinson, D. Goldberg, 2018, The International journal on drug policy.

Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.

T. Rhodes, S. Hutchinson, M. Hickman, 2010, Addiction.

Examining the impact of the first wave of COVID-19 and associated control measures on interventions to prevent blood-borne viruses among people who inject drugs in Scotland: an interrupted time series study

S. Hutchinson, R. Gunson, K. Templeton, 2022, Drug and Alcohol Dependence.

Anthrax infection among heroin users in Scotland during 2009-2010: a case-control study by linkage to a national drug treatment database.

S. Hutchinson, D. Goldberg, N. Palmateer, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

University of Dundee Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs ( EPIToPe )

Ross J. Harris, P. Donnan, A. Presanis, 2019 .

Rapid Decline in HCV Incidence among People Who Inject Drugs Associated with National Scale-Up in Coverage of a Combination of Harm Reduction Interventions

S. Hutchinson, R. Gunson, C. Aitken, 2014, PloS one.

scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings-what is required to achieve the WHO’s HCV elimination targets? Addiction (Abingdon,

P. Vickerman, S. Hutchinson, M. Hickman, 2018 .

Impact of current and scaled‐up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings—what is required to achieve the WHO's HCV elimination targets?

P. Vickerman, S. Hutchinson, M. Hickman, 2018, Addiction.

Exploring Associations Between Perceived HCV Status and Injecting Risk Behaviors Among Recent Initiates to Injecting Drug Use in Glasgow

S. Hutchinson, D. Goldberg, N. Palmateer, 2008, Substance use & misuse.

Modelling the impact of a national scale‐up of interventions on hepatitis C virus transmission among people who inject drugs in Scotland

P. Vickerman, S. Hutchinson, M. Hickman, 2018, Addiction.

Association between harm reduction intervention uptake and skin and soft tissue infections among people who inject drugs.

S. Hutchinson, K. Dunleavy, D. Goldberg, 2017, Drug and alcohol dependence.

Severe Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in a Patient Population Reveals Differences in Virus Exposure and Antibody-Mediated Immunity According to Host Demography and Healthcare Setting

P. Cherepanov, C. Roustan, P. Murcia, 2020, The Journal of infectious diseases.

Infections with Spore-forming Bacteria in Persons Who Inject Drugs, 2000–2009

D. Goldberg, Joanne M. White, N. Palmateer, 2013, Emerging infectious diseases.

Shooting Up: Infections among people who inject drugs in the UK, 2018-an update, December 2019

P. Vickerman, S. Hutchinson, R. Wolstenholme, 2011 .

McDonald, Scott and Hutchinson, Sharon and Palmateer, Norah Elizabeth and Allen, Elizabeth and Cameron, Sheila O. and David J., Goldberg and Taylor, Avril (2013) Decrease in health-related quality of life associated with awareness of hepatitis C virus infection among people

S. Hutchinson, D. Goldberg, N. Palmateer, 2018 .

Decrease in health-related quality of life associated with awareness of hepatitis C virus infection among people who inject drugs in Scotland.

S. Hutchinson, D. Goldberg, N. Palmateer, 2013, Journal of hepatology.

HCV epidemiology in high-risk groups and the risk of reinfection.

J. Macías, J. Pineda, N. Palmateer, 2016, Journal of hepatology.

Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross‐sectional survey data

S. Hutchinson, D. Goldberg, N. Palmateer, 2014, Journal of viral hepatitis.

Reduction in the population prevalence of hepatitis C virus viraemia among people who inject drugs associated with scale-up of direct-acting anti-viral therapy in community drug services: real-world data

S. Hutchinson, M. Hickman, J. Dillon, 2021 .

Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy: Scotland's experience.

H. Innes, S. Hutchinson, J. Dillon, 2015, The International journal on drug policy.

Association between universal hepatitis B prison vaccination, vaccine uptake and hepatitis B infection among people who inject drugs

S. Hutchinson, L. Wallace, R. Gunson, 2018, Addiction.

A decade of spore-forming bacterial infections among European injecting drug users: pronounced regional variation.

Joanne M. White, D. Goldberg, N. Palmateer, 2012, American journal of public health.

Comparison of deaths related to Hepatitis C and AIDS in Scotland

S. Hutchinson, D. Goldberg, N. Palmateer, 2007, Journal of viral hepatitis.

National population prevalence of antibodies to SARS-CoV-2 among pregnant women in Scotland during the second wave of the COVID-19 pandemic: a prospective national serosurvey

G. Reid, C. Robertson, R. Wood, 2021, Public Health.

HCV avidity as a tool for detection of recent HCV infection: Sensitivity depends on HCV genotype

G. Dore, S. Hutchinson, J. Grebely, 2018, Journal of medical virology.

Allen, Elizabeth A. and Palmateer, Norah Elizabeth and Hutchinson, Sharon and Cameron, Sheila O. and Goldberg, David J. and Taylor, Avril (2012) Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites

S. Hutchinson, D. Goldberg, N. Palmateer, 2018 .

Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland.

S. Hutchinson, D. Goldberg, N. Palmateer, 2012, The International journal on drug policy.

University of Dundee Rapid Decline in HCV Incidence among People Who Inject Drugs Associated with National Scale-Up in Coverage of a Combination of Harm Reduction Interventions Palmateer,

S. Hutchinson, R. Gunson, C. Aitken, 2014 .

Review and meta-analysis of the association between self-reported sharing of needles/syringes and hepatitis C virus prevalence and incidence among people who inject drugs in Europe.

H. Innes, S. Hutchinson, M. Hickman, 2013, The International journal on drug policy.

The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.

J. Parry, D. De Angelis, M. May, 2011, Addiction.

Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis

Josephine G. Walker, R. Garfein, J. Havens, 2018, The Lancet. Infectious diseases.

Comparison of SARS-CoV-2 serological assays for use in epidemiological surveillance in Scotland

P. Bieniasz, D. Poston, S. Jenks, 2021, Journal of Clinical Virology Plus.

Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic

L. Wallace, N. Palmateer, D. Goldberg, 2020, Public Health.

Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs

H. Hagan, P. Vickerman, S. Hutchinson, 2017, The Cochrane database of systematic reviews.

Harm reduction among injecting drug users - evidence of effectiveness

T. Rhodes, S. Hutchinson, M. Hickman, 2010 .

National population prevalence of antibodies to SARS-CoV-2 in Scotland during the first and second waves of the COVID-19 pandemic

T. McNeilly, L. Wallace, P. Murcia, 2021, Public Health.

Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta‐analysis

H. Hagan, P. Vickerman, S. Hutchinson, 2017, Addiction.

Interventions to prevent HIV and Hepatitis C among people who inject drugs: Latest evidence of effectiveness from a systematic review (2011 to 2020).

J. Stone, P. Vickerman, S. Hutchinson, 2022, The International journal on drug policy.

Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs

P. Hayes, S. Hutchinson, M. Hickman, 2021, Journal of hepatology.

Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) – a natural experiment (protocol)

Rachel Glass, William Hollingworth, Peter Vickerman, 2019, BMJ Open.

Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis.

M. Hellard, S. Hutchinson, M. Hickman, 2014, International journal of epidemiology.

Recent and Rapid Transmission of HIV Among People Who Inject Drugs in Scotland Revealed Through Phylogenetic Analysis

A. Leigh Brown, R. Gunson, C. Aitken, 2018, The Journal of infectious diseases.

Increased risk of HIV and other drug-related harms associated with injecting in public places: national bio-behavioural survey of people who inject drugs

S. Hutchinson, R. Gunson, D. Goldberg, 2020, The International journal on drug policy.

Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment: a cross-sectional analysis.

S. Hutchinson, R. Gunson, D. Goldberg, 2019, The lancet. HIV.

Increased risk of HIV and other drug-related harms associated with injecting in public places among people who inject drugs in Scotland: a national bio-behavioural survey

S. Hutchinson, R. Gunson, D. Goldberg, 2019, The Lancet.

Evaluation of the scale-up of HIV testing among people who inject drugs in Scotland in the context of an ongoing HIV outbreak.

S. Hutchinson, R. Gunson, D. Goldberg, 2021, The International journal on drug policy.

The uptake of foil from needle and syringe provision services and its role in smoking or snorting heroin among people who inject drugs in Scotland.

S. Hutchinson, K. Dunleavy, R. Gunson, 2021, The International journal on drug policy.

Modelling the prevalence of HCV amongst people who inject drugs: an investigation into the risks associated with injecting paraphernalia sharing.

David Greenhalgh, D. Greenhalgh, S. Hutchinson, 2013, Drug and alcohol dependence.

The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review

S. Hutchinson, D. Goldberg, N. Palmateer, 2010, BMC public health.

Uptake of paraphernalia from injecting equipment provision services and its association with sharing of paraphernalia among injecting drug users in Scotland.

M. Hellard, S. Hutchinson, D. Goldberg, 2012, Drug and alcohol dependence.

The association between alcohol use and hepatitis C status among injecting drug users in Glasgow.

S. Hutchinson, D. Goldberg, N. Palmateer, 2012, Drug and alcohol dependence.

Estimating the variability in the risk of infection for hepatitis C in the Glasgow injecting drug user population

A. Sutton, S. Hutchinson, N. Palmateer, 2012, Epidemiology and Infection.

Risk of Hepatitis C virus re-infection following spontaneous viral clearance in injecting drug users: a systematic review.

D. Greenhalgh, S. Hutchinson, S. Corson, 2011, The International journal on drug policy.

Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs.

H. Hagan, P. Vickerman, S. Hutchinson, 2016, The Cochrane database of systematic reviews.

High willingness to use drug consumption rooms among people who inject drugs in Scotland: findings from a national bio-behavioural survey among people who inject drugs

H. Sumnall, S. Hutchinson, A. Atkinson, 2020, The International journal on drug policy.

Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis.

Josephine G. Walker, N. Luhmann, A. Trickey, 2023, The lancet. Gastroenterology & hepatology.

REDUCTION IN THE POPULATION PREVALENCE OF HCV VIRAEMIA AMONG PEOPLE WHO INJECT DRUGS ASSOCIATED WITH SCALE-UP OF DIRECT-ACTING ANTIVIRAL THERAPY IN COMMUNITY DRUG SERVICES: REAL WORLD DATA.

P. Hayes, S. Hutchinson, M. Hickman, 2021, Addiction.

ADecadeofSpore- InfectionsAmonggDrug Users:Pronouncedn

D. Malouf, G. Harper, R. Garofalo, 2012 .

Spore forming bacteria infections and people who inject drugs: Implications for harm reduction.

S. Hutchinson, K. Dunleavy, D. Goldberg, 2018, The International journal on drug policy.